← Leaderboards
Heidi E Hamm
Vanderbilt University
$26,815,301
Attributed
$30,211,862
Total exposure
20
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,665,552 · 21
By mechanism
R01$21,362,049 · 10
T32$2,576,822 · 1
RF1$2,185,927 · 1
P50$2,085,140 · 1
P01$1,066,136 · 1
S10$907,380 · 5
Top collaborators
- Simon T Alford5 shared
- Jens Meiler3 shared
- Shaun R Stauffer3 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Simon T Alford$5,940,388
- Richard N Pierson$28,134,227
- Randy D Blakely$29,330,449
- Uhna Sung$344,224
- P Jeffrey Conn$37,782,937
Others in their field
Top investigators on “Site”
- Lawrence Corey · Fred Hutchinson Cancer Center$727,416,881
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$630,131,001
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
SiteMediatingReceptorSignal TransductionGtp-Binding ProteinsEventG-Protein-Coupled ReceptorsAffinityMolecularComplexGrantThrombinPlayAgonistPhysiologicalProteinsPeptidesMembraneCoupledResponseBaseReceptor BindingAlzheimer&AposLearning
Grant awards (81)
Cerebrovascular involvement in Alzheimer's Disease: PAR4 Antagonism$673,580
R01 · FY2025 · AG · contact PI
Cerebrovascular involvement in Alzheimer's Disease: PAR4 Antagonism$703,176
R01 · FY2024 · AG · contact PI
Regulation of exocytosis by direct Gbg blockade of fusion$402,313
R01 · FY2023 · NS · contact PI
Regulation of exocytosis by direct Gbg blockade of fusion$404,951
R01 · FY2022 · NS · contact PI
Role of Protease Activated Receptor 4 in cerebrovascular dysfunction and dementia$243,549
R21 · FY2022 · AG · contact PI
Cerebrovascular involvement in Alzheimer's Disease: PAR4 Antagonism$2,185,927
RF1 · FY2021 · AG · contact PI
Regulation of exocytosis by direct Gbg blockade of fusion$407,589
R01 · FY2021 · NS · contact PI
Role of Protease Activated Receptor 4 in cerebrovascular dysfunction and dementia$218,549
R21 · FY2021 · AG · contact PI
Targeting PAR4 in Thrombotic Disorders:Pharmacogenomic Approach$754,865
R01 · FY2020 · HL · contact PI
Regulation of exocytosis by direct Gbg blockade of fusion$407,589
R01 · FY2020 · NS · contact PI
Targeting PAR4 in Thrombotic Disorders:Pharmacogenomic Approach$544,966
R01 · FY2019 · HL · contact PI
Regulation of exocytosis by direct Gbg blockade of fusion$421,839
R01 · FY2019 · NS · contact PI
GPCR Regulation of insulin secretion by modulation of the release machinery$352,660
R01 · FY2019 · DK · contact PI
Targeting PAR4 in Thrombotic Disorders:Pharmacogenomic Approach$515,145
R01 · FY2018 · HL · contact PI
GPCR Regulation of insulin secretion by modulation of the release machinery$352,660
R01 · FY2018 · DK · contact PI
Targeting PAR4 in Thrombotic Disorders:Pharmacogenomic Approach$451,921
R01 · FY2017 · HL · contact PI
GPCR Regulation of insulin secretion by modulation of the release machinery$352,660
R01 · FY2017 · DK · contact PI
Immunological studies of visual transduction pathways$235,500
R01 · FY2017 · EY · contact PI
Optimization of modulators of Gbg-SNARE interaction$391,357
R01 · FY2016 · MH · contact PI
GPCR Regulation of insulin secretion by modulation of the release machinery$352,660
R01 · FY2016 · DK · contact PI
Optimization of modulators of Gbg-SNARE interaction$394,050
R01 · FY2015 · MH · contact PI
Immunological studies of visual transduction pathways$382,200
R01 · FY2015 · EY · contact PI
Optimization of PAR4 antagonists for thrombotic disorders$343,438
R01 · FY2015 · NS · contact PI
Screening for allosteric modulators of the protease activated receptor 4$343,138
R01 · FY2015 · NS · contact PI
Optimization of modulators of Gbg-SNARE interaction$400,752
R01 · FY2014 · MH · contact PI
Immunological studies of visual transduction pathways$382,200
R01 · FY2014 · EY · contact PI
Optimization of PAR4 antagonists for thrombotic disorders$340,003
R01 · FY2014 · NS · contact PI
Screening for allosteric modulators of the protease activated receptor 4$339,706
R01 · FY2014 · NS · contact PI
Immunological studies of visual transduction pathways$370,500
R01 · FY2013 · EY · contact PI
Optimization of PAR4 antagonists for thrombotic disorders$341,615
R01 · FY2013 · NS · contact PI
Screening for allosteric modulators of the protease activated receptor 4$341,137
R01 · FY2013 · NS · contact PI
Immunological studies of visual transduction pathways$390,000
R01 · FY2012 · EY · contact PI
Immunological studies of visual transduction pathways$368,400
R01 · FY2011 · EY · contact PI
ROLE OF PAR RECEPTORS IN HUMAN PLATELET FUNCTION$440,601
P50 · FY2010 · HL · contact PI
Immunological studies of visual transduction pathways$379,913
R01 · FY2010 · EY · contact PI
G Protein Structure and Function$368,896
R01 · FY2010 · EY · contact PI
ROLE OF PAR RECEPTORS IN HUMAN PLATELET FUNCTION$427,204
P50 · FY2009 · HL · contact PI
Regulation of vascular permeability by thrombin mediated signaling pathways$424,185
R01 · FY2009 · HL · contact PI
Immunological studies of visual transduction pathways$383,750
R01 · FY2009 · EY · contact PI
G Protein Structure and Function$372,621
R01 · FY2009 · EY · contact PI
Regulation of vascular permeability by thrombin mediated signaling pathways$15,500
R01 · FY2009 · HL · contact PI
ROLE OF PAR RECEPTORS IN HUMAN PLATELET FUNCTION$409,228
P50 · FY2008 · HL · contact PI
Immunological studies of visual transduction pathways$376,075
R01 · FY2008 · EY · contact PI
Regulation of vascular permeability by thrombin mediated signaling pathways$372,621
R01 · FY2008 · HL · contact PI
G Protein Structure and Function$365,169
R01 · FY2008 · EY · contact PI
Regulation of vascular permeability by thrombin mediated signaling pathways$44,299
R01 · FY2008 · HL · contact PI
ROLE OF PAR RECEPTORS IN HUMAN PLATELET FUNCTION$411,430
P50 · FY2007 · HL · contact PI
Immunological studies of visual transduction pathways$383,322
R01 · FY2007 · EY · contact PI
G Protein Structure and Function$372,621
R01 · FY2007 · EY · contact PI
Regulation of vascular permeability by thrombin mediated signaling pathways$372,319
R01 · FY2007 · HL · contact PI
Training in Pharmacological Sciences$367,779
T32 · FY2007 · GM · contact PI
Training in Pharmacological Sciences$533,538
T32 · FY2006 · GM · contact PI
ROLE OF PAR RECEPTORS IN HUMAN PLATELET FUNCTION$396,677
P50 · FY2006 · HL · contact PI
G Protein Structure and Function$382,500
R01 · FY2006 · EY · contact PI
Regulation of vascular permeability by thrombin mediated signaling pathways$381,875
R01 · FY2006 · HL · contact PI
Training in Pharmacological Sciences$511,274
T32 · FY2005 · GM
G Protein Structure and Function$377,500
R01 · FY2005 · EY
Immunological studies of visual transduction pathways$130,799
R01 · FY2005 · EY
Training in Pharmacological Sciences$586,891
T32 · FY2004 · GM
Acquisition of a FLIPR 3 system (384-well Type B head)$453,690
S10 · FY2004 · RR
G Protein Structure and Function$377,500
R01 · FY2004 · EY
Immunological studies of visual transduction pathways$377,500
R01 · FY2004 · EY
FLIPR 3 SYST: CANCER$113,423
S10 · FY2004 · RR
FLIPR 3 SYST: ANIMAL MODELS: C ELEGANS, MOUSE$113,423
S10 · FY2004 · RR
FLIPR 3 SYST: PROTEINS &GENETICS$113,423
S10 · FY2004 · RR
FLIPR 3 SYST: PROTEINS &NEUROSCIENCE: PARKINSON$113,421
S10 · FY2004 · RR
Mathematical Models in Signaling Systems$20,000
R13 · FY2004 · GM
Training in Pharmacological Sciences$577,340
T32 · FY2003 · GM
G Protein Structure and Function$377,500
R01 · FY2003 · EY
Immunological studies of visual transduction pathways$377,500
R01 · FY2003 · EY
Immunological studies of visual transduction pathways$377,500
R01 · FY2002 · EY
G Protein Structure and Function$377,500
R01 · FY2002 · EY
PAR G protein signaling of endothelial activation$266,534
P01 · FY2002 · HL
PAR G protein signaling of endothelial activation$266,534
P01 · FY2001 · HL
G PROTEIN STRUCTURE/FUNCTION$249,290
R01 · FY2001 · EY
IMMUNOLOGICAL STUDIES OF VISUAL TRANSDUCTION PATHWAYS$183,436
R01 · FY2001 · EY
IMMUNOLOGICAL STUDIES OF VISUAL TRANSDUCTION PATHWAYS$144,706
R01 · FY2001 · EY
IMMUNOLOGICAL STUDIES OF VISUAL TRANSDUCTION PATHWAYS$316,645
R01 · FY2000 · EY
PAR G protein signaling of endothelial activation$266,534
P01 · FY2000 · HL
PAR G protein signaling of endothelial activation$266,534
P01 · FY2000 · HL
G PROTEIN STRUCTURE/FUNCTION$236,437
R01 · FY2000 · EY